Meanwhile, study by [13] showed that the autoregulatory negative feedback loop involving regulation of p53 by Murine Double Minute 2 (MDM2) could be a novel target therapy in cancer treatment as these two genes regulate each other mutually through an autoregulatory negative feedback loop. This evidence concerns the gene MDM2 and cancer.